Bormann-Kennedy Barbara-Jean Anne
Director at XERS
- Sold, on record
- $204k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Jun 4, 2026
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- XERSXeris Biopharma Holdings, Inc.Director
Sales by reason
2
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice XERSNoticeDec 12, 2025 2025
Filed to sell 15,000 shares ($105k)
Bormann-Kennedy Barbara-Jean Anne, Director
10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale XERSRoutineDec 12, 2025 same day
Sold 15,000 shares at $7.09 ($106k)
Bormann-Kennedy Barbara-Jean Anne, Director
10b5-1 planSold 9.5% of holdings ($1.1M position)142,500 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 4 sale XERSRoutineJun 4, 2026 +174 days
Sold 16,000 shares at $6.09 ($97k)
Bormann-Kennedy Barbara-Jean Anne, Director
10b5-1 planSold 11.2% of holdings ($868k position)126,500 shares leftFiling
Every transaction
Loading transactions…